Bilal Dar, MD
Anesthesiology · Houston, TXNPI 1174910392
Payments from drug & device makers
Across 277 payments — averaging $36.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Abbott$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$975
- Medtronic$923
- Nevro Corp.$527
- Collegium Pharmaceutical, Inc.$340
- plus $2K from 25 others
What the payments were for
- Travel & lodging$2,76127%
- Food & beverage$7,34772%
- Education$1281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 31 | $2,674 |
| Abbott | 28 | $2,477 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 55 | $975 |
| Medtronic(2 entities) | 21 | $923 |
| Nevro Corp. | 12 | $527 |
| Collegium Pharmaceutical, Inc. | 20 | $340 |
| Saluda Medical Americas, Inc. | 9 | $299 |
| GRT US Holding, Inc. | 10 | $297 |
| AbbVie | 15 | $231 |
| Painteq LLC | 17 | $204 |
| Scilex Pharmaceuticals Inc. | 10 | $189 |
| Lundbeck LLC | 7 | $175 |
| Hikma Pharmaceuticals USA | 8 | $135 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $120 |
| Pfizer | 5 | $114 |
| Biotronik NRO, Inc. | 1 | $110 |
| Redhill Biopharma Inc. | 3 | $62 |
| SPR Therapeutics, Inc | 1 | $45 |
| Johnson & Johnson | 3 | $42 |
| Biodelivery Sciences International, Inc. | 3 | $40 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| Globus Medical | 1 | $37 |
| Trice Medical, Inc. | 1 | $28 |
| Azurity Pharmaceuticals, Inc. | 2 | $27 |
| Vertos Medical, Inc. | 1 | $26 |
| Amgen | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Protega Pharmaceutials Inc | 1 | $14 |
| Averitas Pharma Inc. | 1 | $13 |
| Epimed International, Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$1,156
- PROCLAIM$831
- Superion Indirect Decompression System$829
- VERCISE$787
- INTELLIS ADAPTIVESTIM$334
- GENERAL PAIN MANAGEMENT$253
- WaveWriter Alpha Prime 16$229
- Qutenza$162
- CLINICAL TRIAL PRODUCT$148
- Evoke$144
- Senza Spinal Cord Stimulation System$118
- Prospera$110
- RESTORE$107
- RELISTOR$102
How this compares
$10,236 in reported general payments places this provider in the 95th percentile of 3,899 anesthesiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,328 | $61,108 |
| NucyntaTapentadol Hcl | 12 | $12,037 |
| Naloxone Hcl | 191 | $11,068 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 56 | $9,850 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 339 | $7,907 |
| ZtlidoLidocaine | 22 | $7,658 |
| Hysingla ErHydrocodone Bitartrate | 13 | $6,749 |
| Xtampza ErOxycodone Myristate | 15 | $6,639 |
| Lidocaine | 34 | $4,279 |
| Gabapentin | 424 | $3,466 |
| Pregabalin | 160 | $2,209 |
| Tizanidine Hcl | 341 | $2,138 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 123 | $2,112 |
| Fentanyl | 32 | $1,869 |
| Oxycodone Hcl | 99 | $1,083 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er | $340 | $18,67627 claims |
| Hikma Pharmaceuticals USABuprenorphine-Naloxone, Morphine Sulfate, Buprenorphine Hcl | $135 | $10,56798 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $189 | $7,65822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,899 anesthesiology providers in Texas.
Other anesthesiology in Houston
- David BrownHouston$2.5M
- Holger EltzschigHouston$1.6M
- Maria MatuszczakHouston$907K
- Tong GanHouston$703K
- Gabriel MenaHouston$494K
- Juan CataHouston$387K
- Harold MinkowitzHouston$241K
- Eric ChanHouston$128K
- John ZakiHouston$109K
- Farzin GoravanchiHouston$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.